A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.
Saved in:
| Title: | A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer. |
|---|---|
| Authors: | Hye Ryeon Kim1, Su Jin Lee2, Sehhoon Park1, Hyun Ae Jung1, Se-Hoon Lee1, Han-Sin Jeong3, Man Ki Chung3, Myung-Ju Ahn1 silkahn@skku.edu |
| Source: | Cancer Research & Treatment. Jul2022, Vol. 54 Issue 3, p719-727. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 15982998 |
|---|---|
| DOI: | 10.4143/crt.2021.1019 |
